Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria
ABSTRACT Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematologic disorder treated with complement inhibitors. Currently, patients with suboptimal response to C5 inhibitors may be switched to proximal complement inhibitors, such as pegcetacoplan, danicopan, or iptacopan. H...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2026-04-01
|
| シリーズ: | eJHaem |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/jha2.70298 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|